Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma
Authors:
- 30 April 2014
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 37 (5) , 630-635
Abstract
Background The optimal treatment for patients with recurrent human papillomavirus (HPV)‐positive head and neck cancer is poorly understood. Methods We investigated treatments and outcomes in patients with recurrent head and neck cancer. Treatments included salvage neck surgery, metastasectomy, hypofractionated reirradiation, chemoembolization, and chemotherapy. Treatment outcomes were compared based on HPV status. Results A total of 37 patients were identified (12 HPV positive and 25 HPV negative). Demographics were similar. Overall, there was a trend toward a higher number of total treatment interventions in patients with HPV‐positive disease (4.5 vs 2.6), but this was statistically insignificant (p = .066). After a mean follow‐up of 21 months, median survival in HPV‐negative patients was 10.6 months, whereas the median survival had not been reached for HPV‐positive patients. Of the 12 HPV‐positive patients, 7 were still alive (58%) after a mean follow‐up period of 33 months. Conclusion Multimodality aggressive therapy may improve overall survival in patients with recurrent HPV‐positive disease. Further prospective research is warranted. © 2014 Wiley Periodicals, Inc. Head Neck, 2014Keywords
This publication has 28 references indexed in Scilit:
- Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal CancerJournal of Clinical Oncology, 2012
- Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapyJournal of Radiation Oncology, 2012
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1Science, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor RecurrenceClinical Cancer Research, 2010
- Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical ImplicationsClinical Cancer Research, 2009
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neckHead & Neck, 2007
- Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means?The Laryngoscope, 2000